Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP programmes and uptake news

Show

From To
Men who have sex with men in China are unsure about PrEP

Gay men in China could benefit from more information around PrEP to increase uptake and curb new HIV infections in this group.

Published
24 February 2019
From
AVERT
Cocaine use associated with poor adherence to PrEP and dropping out of care

Cocaine users have poorer adherence to HIV pre-exposure prophylaxis (PrEP) and engagement with care, according to research published in the online edition of the Journal of Acquired

Published
22 February 2019
By
Michael Carter
In the USA, only two in five PrEP users keep taking it over two years

Real-world data from a large American chain of retail pharmacies show that only two in five people keep on taking pre-exposure prophylaxis (PrEP) for two years after

Published
21 February 2019
By
Roger Pebody
Viet Nam announces nationwide rollout of PrEP

Dr Heather-Marie Schmidt, WHO/UNAIDS Regional PrEP Advisor for Asia and the Pacific, spoke to Associate Professor Phan Thi Thu Huong, Deputy Director General of the Viet Nam Authority of HIV/AIDS Control, about PrEP in Viet Nam.

Published
19 February 2019
From
World Health Organization
Gay men in New York rate an undetectable viral load as less effective than PrEP

Gay, bisexual and other men who have sex with men in New York City rate daily pre-exposure prophylaxis (PrEP) as the most effective HIV prevention strategy when

Published
19 February 2019
By
Roger Pebody
While The NHS Drags Its Heels On PrEP, This Is How Men Are Being Affected

Although NHS England increased places in the PrEP Impact Trial to 13,000 participants in summer and recently said it hopes to extend this to 26,000 before 2020, it is yet to confirm when these places will become available – or what will happen when the three-year trial is up. Around 40% of trial clinics across England are currently turning away gay and bisexual men due to oversubscription, according to the Terrence Higgins Trust. Six men who’ve failed to access PrEP have told HuffPost UK the experience has left them feeling “depressed”, “anxious” and “frustrated”.

Published
12 February 2019
From
Huffington Post
To Halt HIV, Advocates Push For PrEP Outreach To Black Women

In 2013, not quite a year after the Food and Drug Administration approved the drug Truvada for HIV prevention, a coalition of 50 experts in HIV and women's health called on U.S. public health agencies to promote the pill and its approach, called pre-exposure prophylaxis, or PrEP, explicitly to women. Not much happened.

Published
11 February 2019
From
NPR
What's Going On with the NHS PrEP Trial in England?

NHS Engalnd delayed plans to fund doubling the trial in size, just days after its announcement – and that may leave people at even greater risk.

Published
04 February 2019
From
Vice
“Nothing feels better than being confident that you are healthy” – a young man’s experience of PrEP

PrEP recently became available in Ukraine, and for Georgii Onyschuk, a 29-year-old marketing professional from Kyiv, it has become a normal part of life as a young gay man.

Published
30 January 2019
From
World Health Organization
For the greatest impact, end caps on PrEP access now

NHS England continues to limit the roll-out of PrEP. Waiting until the Impact trial completes is reckless—for the greatest impact, make PrEP available now to all who need it.

Published
25 January 2019
From
Lancet HIV (editorial)

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.